Earlier studies acknowledged the hyperangiogenic state of ccRCC and the mechanism of action of VEGF-targeted tyrosine kinase inhibitors (TKIs) as a rationale for studying the components of the VEGF signaling cascade. This evidence concerns the gene VEGFA and nonpapillary renal cell carcinoma.